The fundamental basis of inflammatory bowel disease

被引:1073
作者
Strober, Warren [1 ]
Fuss, Ivan [1 ]
Mannon, Peter [1 ]
机构
[1] NIAID, Mucosal Immun Sect, Host Def Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1172/JCI30587
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
Two broad hypotheses have arisen regarding the fundamental nature of the pathogenesis of inflammatory bowel diseases (IBDs, which include ulcerative colitis and Crohn disease). The first contends that primary dysregulation of the mucosal immune system leads to excessive immunologic responses to normal microflora. The second suggests that changes in the composition of gut microflora and/or deranged epithelial barrier function elicits pathologic responses from the normal mucosal immune system. Here we examine these hypotheses and conclude that IBD is indeed characterized by an abnormal mucosal immune response but that microbial factors and epithelial cell abnormalities can facilitate this response.
引用
收藏
页码:514 / 521
页数:8
相关论文
共 83 条
[1]
The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO [J].
Abbott, DW ;
Wilkins, A ;
Asara, JM ;
Cantley, LC .
CURRENT BIOLOGY, 2004, 14 (24) :2217-2227
[2]
Natalizumab and progressive multifocal leukoencephalopathy [J].
Adelman, B ;
Sandrock, A ;
Panzara, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (04) :432-433
[3]
Cdcs1, a major colitogenic locus in mice, regulates innate and adaptive immune response to enteric bacterial antigens [J].
Beckwith, J ;
Cong, YZ ;
Sundberg, JP ;
Elson, CO ;
Leiter, EH .
GASTROENTEROLOGY, 2005, 129 (05) :1473-1484
[4]
The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients [J].
Bibiloni, Rodrigo ;
Mangold, Marco ;
Madsen, Karen L. ;
Fedorak, Richard N. ;
Tannock, Gerald W. .
JOURNAL OF MEDICAL MICROBIOLOGY, 2006, 55 (08) :1141-1149
[5]
Complications of biological therapy for inflammatory bowel diseases [J].
Blonski, W ;
Lichtenstein, GR .
CURRENT OPINION IN GASTROENTEROLOGY, 2006, 22 (01) :30-43
[6]
A phase I trial with Transgenic bacteria expressing interleukin-10 in Crohn's disease [J].
Braat, Henri ;
Rottiers, Pieter ;
Hommes, Daniel W. ;
Huyghebaert, Nathalie ;
Remaut, Erik ;
Remon, Jean-Paul ;
Van Deventer, Sander J. H. ;
Neirynck, Sabine ;
Peppelenbosch, Maikel P. ;
Steidler, Lothar .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (06) :754-759
[7]
Brandwein SL, 1997, J IMMUNOL, V159, P44
[8]
CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice:: Increased T helper cell type 1 response and ability to transfer disease [J].
Cong, YZ ;
Brandwein, SL ;
McCabe, RP ;
Lazenby, A ;
Birkenmeier, EH ;
Sundberg, JP ;
Elson, CO .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (06) :855-864
[9]
Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis [J].
Creed, TJ ;
Norman, MR ;
Probert, CSJ ;
Harvey, RF ;
Shaw, IS ;
Smithson, J ;
Anderson, J ;
Moorghen, M ;
Gupta, J ;
Shepherd, NA ;
Dayan, CM ;
Hearing, SD .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (01) :65-75
[10]
Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease [J].
Darfeuille-Michaud, A ;
Neut, C ;
Barnich, N ;
Lederman, E ;
Di Martino, P ;
Desreumaux, P ;
Gambiez, L ;
Joly, B ;
Cortot, A ;
Colombel, JF .
GASTROENTEROLOGY, 1998, 115 (06) :1405-1413